
Katrina Altersitz Wells
Vice President, Editorial Features at Healio
Vice President, Editorial Features at Healio Aesthetics
Vice President, Editorial Features at Healio Dermatology
Editor working in gastro/hep and creating my own path after receiving my #BRCA1 diagnosis http://t.co/4IlVNkrtJ2
Articles
-
4 days ago |
healio.com | Katrina Altersitz Wells
CHICAGO — Healio | HemOnc Today hosted its fourth Disruptive Innovators Awards ceremony, crowning nine new winners at ASCO Annual Meeting. Co-hosted by Shikha Jain, MD, FACP, founder of Women in Medicine, and Ed S. Kim, MD, of City of Hope, these awards honor those in the hematology/oncology space who are positively disrupting the field and pushing the status quo to improve clinical practice.
-
Mar 7, 2025 |
healio.com | Edward Kim |Shikha Jain |Eleonora Teplinsky |Katrina Altersitz Wells
Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology. Individuals who changed the face of the specialty and pushed the status quo toward betterment of the field will be recognized during a live event at ASCO Annual Meeting. In this video, awards ceremony co-hosts Shikha Jain, MD, FACP, and Edward S.
-
Dec 15, 2024 |
healio.com | Katrina Altersitz Wells
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN ANTONIO — Weight loss via lifestyle intervention showed correlation to improved inflammatory markers in a group of women with HER2-negative breast cancer, according to a presenter here. Jennifer A.
-
Dec 14, 2024 |
healio.com | Katrina Altersitz Wells
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN ANTONIO — Combining a poly(ADP-ribose) polymerase inhibitor with a PD-1 antibody in a nonchemotherapy regimen for BRCA-mutated breast cancer showed promise, according to a presenter here. Erica L.
-
Nov 27, 2024 |
healio.com | Erin Michael |Katrina Altersitz Wells
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways A new ultrasound approach helped identify patients later diagnosed with biliary atresia. The method would provide a quicker, less invasive approach that would not require fasting.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 507
- Tweets
- 1K
- DMs Open
- No

RT @AustinChiangMD: BIG CONGRATS to @spaulliver and @drfolamay, who both won @GoHealio awards yesterday!!! 💚🎉💚🎉 #ACG2023 #DiversityInGI ht…

https://t.co/3xfG3VaOgT #UltimateSoccerWatchParty #Sponsored

RT @ErasTourResell: oh hi 🫶🏼